AFT — AFT Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- NZ$338.72m
- NZ$373.50m
- NZ$156.64m
- 87
- 21
- 46
- 53
Annual cashflow statement for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash from Operating Activities | 1.07 | 14.9 | 0.75 | 14.2 | 11.6 |
| Capital Expenditures | -3.46 | -6.56 | -6.23 | -5.58 | -9.18 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.42 | 0 | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.88 | -6.56 | -6.23 | -5.58 | -9.18 |
| Financing Cash Flow Items | -3.56 | -5.9 | -4.19 | -2.19 | -2.86 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.72 | -9.12 | 2.52 | -2.28 | -6.98 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.146 | -0.797 | -2.91 | 6.39 | -4.65 |